The correlates of benefit from neoadjuvant chemotherapy before surgery in non-small-cell lung cancer: a metaregression analysis

Bozcuk, Hakan; Abalı, Hakan; Çoşkun, Şenol; Aydıner, Adnan; Çinkaya, Ahmet; Demirkazık, Ahmet; Özet, Ahmet; Yolcu, Ahmet; Balkan, Arzu; Çavdar, Ayhan; Üçüncü Kefeli, Ayşegül; Oyan Uluç, Başak; Atasoy, Beste; Demirkan, Hatice; Yalçın, Bülent; Eroğlu, Celaleddin; Yalman, Deniz; Kılıç, Diclehan; Tunalı, Didem; Fırat, Dinçer; Seber, Selçuk; Cavuşoğlu, Emel; Ulukaya, Engin; Kaytan Sağlam, Esra; Tezcanlı Tjon A Meeuw, Evrim; Eryılmaz, Işıl; Dinçbaş, Hidayet; Telli, Ferhat; Yumuk, Perran; Başaran, Gül; Çağlar, Hale; Sönmez, Halil; Yılmaz, Hasan; Engin, Hüseyin; Helvacı, Kaan; Sönmez, Kemal; Koral, Lokman; Artaç, Mehmet; Eren, Mehmet; Koçar, Muharrem; Beyzadeoğlu, Mehmet; Akın, Mustafa; Benekli, Mustafa; Cengiz, Mustafa; Erman, Mustafa; Yıldız, Mustafa; Doğan, Mutlu; Balkan, Salih; Eraktuğ, Nil; Ünal, Olçun; Şencan, Orhan; Erpolat, Özge; Saip, Pınar; Kılıçkap, Sadettin; Okkan, Sait; Seber, E; Paydaş, Semra; Sarıhan, SÜREYYA; Kömürcü, Şeref; Demirkasımoğlu, Taciser; Korkmaz, Taner; Yetişyiğit, Tarkan; Yavuzşen, Tuğba; Evrensel, TÜRKKAN; Akman, Tülay; Abacıoğlu, Mehmet; Kefeli, Umut; Egeli, Ünal; Elgin, Yeşim; Baran, Yusuf; Bulut, Zeynep

doi:10.1186/1477-7819-10-161

The correlates of benefit from neoadjuvant chemotherapy before surgery in non-small-cell lung cancer: a metaregression analysis

Atıf İçin Kopyala

Bozcuk H., Abalı H., Çoşkun Ş., Aydıner A., Çinkaya A., Demirkazık A., ...Daha Fazla

WORLD JOURNAL OF SURGICAL ONCOLOGY, cilt.10, 2012 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 10
Basım Tarihi: 2012
Doi Numarası: 10.1186/1477-7819-10-161
Dergi Adı: WORLD JOURNAL OF SURGICAL ONCOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Anahtar Kelimeler: Meta-analysis, Metaregression, Mortality, Neoadjuvant chemotherapy, Non-small-cell lung cancer, COMPARING PERIOPERATIVE CHEMOTHERAPY, INDUCTION CHEMOTHERAPY, PLUS SURGERY, METAANALYSIS, GEMCITABINE, CARCINOMA
Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Background: Although neoadjuvant chemotherapy (NCT) is widely used, it is not clear which subgroup of locally advanced non-small-cell lung cancer (NSCLC) patients should be treated with this approach, and if a particular benefit associated with NCT exists. In this study, we aimed to investigate the potential correlates of benefit from NCT in patients with NSCLC.